Eufauserase
Alternative Names: PHM-101Latest Information Update: 14 Nov 2003
At a glance
- Originator University of Cambridge
- Class Antivirals; Serine endopeptidases
- Mechanism of Action Serine endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 14 Nov 2003 Discontinued - Preclinical for Herpes simplex virus infections in United Kingdom (Topical)
- 21 Jun 2001 No-Development-Reported for Herpes simplex virus infections in United Kingdom (Topical)
- 16 Nov 1998 Preclinical development for Herpes simplex virus infections in United Kingdom (Topical)